The global market for Dehydroepiandrosterone Therapy (DHEA) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Dehydroepiandrosterone (DHEA) is an adrenal steroid hormone that is mainly converted into testosterone and estrogen in the body. DHEA acts as a hormone precursor in the body and affects the balance of hormones in the body. It is often used as a supplement to improve physical fitness, enhance immune function and anti-aging.

North American market for Dehydroepiandrosterone Therapy (DHEA) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Dehydroepiandrosterone Therapy (DHEA) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Dehydroepiandrosterone Therapy (DHEA) include Jarrow Formulas, Acetar Bio-Tech, GNC, Schiff Vitamins, Natrol, Nature’s Bounty, Shanghai Jinli Biotech, Lisi (Xian) Bio-Tech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dehydroepiandrosterone Therapy (DHEA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dehydroepiandrosterone Therapy (DHEA).

The Dehydroepiandrosterone Therapy (DHEA) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dehydroepiandrosterone Therapy (DHEA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dehydroepiandrosterone Therapy (DHEA) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dehydroepiandrosterone Therapy (DHEA) Market Report

Report Metric	Details
Report Name	Dehydroepiandrosterone Therapy (DHEA) Market
Segment by Type	Powder Tablet Other
Segment by Application	Medicine Laboratory
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Jarrow Formulas, Acetar Bio-Tech, GNC, Schiff Vitamins, Natrol, Nature’s Bounty, Shanghai Jinli Biotech, Lisi (Xian) Bio-Tech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dehydroepiandrosterone Therapy (DHEA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dehydroepiandrosterone Therapy (DHEA) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Dehydroepiandrosterone Therapy (DHEA) Market report?

Ans: The main players in the Dehydroepiandrosterone Therapy (DHEA) Market are Jarrow Formulas, Acetar Bio-Tech, GNC, Schiff Vitamins, Natrol, Nature’s Bounty, Shanghai Jinli Biotech, Lisi (Xian) Bio-Tech

What are the Application segmentation covered in the Dehydroepiandrosterone Therapy (DHEA) Market report?

Ans: The Applications covered in the Dehydroepiandrosterone Therapy (DHEA) Market report are Medicine, Laboratory

What are the Type segmentation covered in the Dehydroepiandrosterone Therapy (DHEA) Market report?

Ans: The Types covered in the Dehydroepiandrosterone Therapy (DHEA) Market report are Powder, Tablet, Other

1 Dehydroepiandrosterone Therapy (DHEA) Market Overview

1.1 Product Definition

1.2 Dehydroepiandrosterone Therapy (DHEA) by Type

1.2.1 Global Dehydroepiandrosterone Therapy (DHEA) Market Value Comparison by Type (2024 VS 2031)

1.2.2 Powder

1.2.3 Tablet

1.2.4 Other

1.3 Dehydroepiandrosterone Therapy (DHEA) by Application

1.3.1 Global Dehydroepiandrosterone Therapy (DHEA) Market Value by Application (2024 VS 2031)

1.3.2 Medicine

1.3.3 Laboratory

1.4 Global Dehydroepiandrosterone Therapy (DHEA) Market Size Estimates and Forecasts

1.4.1 Global Dehydroepiandrosterone Therapy (DHEA) Revenue 2020-2031

1.4.2 Global Dehydroepiandrosterone Therapy (DHEA) Sales 2020-2031

1.4.3 Global Dehydroepiandrosterone Therapy (DHEA) Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Dehydroepiandrosterone Therapy (DHEA) Market Competition by Manufacturers

2.1 Global Dehydroepiandrosterone Therapy (DHEA) Sales Market Share by Manufacturers (2020-2025)

2.2 Global Dehydroepiandrosterone Therapy (DHEA) Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Dehydroepiandrosterone Therapy (DHEA) Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Dehydroepiandrosterone Therapy (DHEA), Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Dehydroepiandrosterone Therapy (DHEA), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Dehydroepiandrosterone Therapy (DHEA), Product Type & Application

2.7 Global Key Manufacturers of Dehydroepiandrosterone Therapy (DHEA), Date of Enter into This Industry

2.8 Global Dehydroepiandrosterone Therapy (DHEA) Market Competitive Situation and Trends

2.8.1 Global Dehydroepiandrosterone Therapy (DHEA) Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Dehydroepiandrosterone Therapy (DHEA) Players Market Share by Revenue

2.8.3 Global Dehydroepiandrosterone Therapy (DHEA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Dehydroepiandrosterone Therapy (DHEA) Market Scenario by Region

3.1 Global Dehydroepiandrosterone Therapy (DHEA) Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Dehydroepiandrosterone Therapy (DHEA) Sales by Region: 2020-2031

3.2.1 Global Dehydroepiandrosterone Therapy (DHEA) Sales by Region: 2020-2025

3.2.2 Global Dehydroepiandrosterone Therapy (DHEA) Sales by Region: 2026-2031

3.3 Global Dehydroepiandrosterone Therapy (DHEA) Revenue by Region: 2020-2031

3.3.1 Global Dehydroepiandrosterone Therapy (DHEA) Revenue by Region: 2020-2025

3.3.2 Global Dehydroepiandrosterone Therapy (DHEA) Revenue by Region: 2026-2031

3.4 North America Dehydroepiandrosterone Therapy (DHEA) Market Facts & Figures by Country

3.4.1 North America Dehydroepiandrosterone Therapy (DHEA) Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Dehydroepiandrosterone Therapy (DHEA) Sales by Country (2020-2031)

3.4.3 North America Dehydroepiandrosterone Therapy (DHEA) Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Dehydroepiandrosterone Therapy (DHEA) Market Facts & Figures by Country

3.5.1 Europe Dehydroepiandrosterone Therapy (DHEA) Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Dehydroepiandrosterone Therapy (DHEA) Sales by Country (2020-2031)

3.5.3 Europe Dehydroepiandrosterone Therapy (DHEA) Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Dehydroepiandrosterone Therapy (DHEA) Market Facts & Figures by Region

3.6.1 Asia Pacific Dehydroepiandrosterone Therapy (DHEA) Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Dehydroepiandrosterone Therapy (DHEA) Sales by Region (2020-2031)

3.6.3 Asia Pacific Dehydroepiandrosterone Therapy (DHEA) Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Dehydroepiandrosterone Therapy (DHEA) Market Facts & Figures by Country

3.7.1 Latin America Dehydroepiandrosterone Therapy (DHEA) Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Dehydroepiandrosterone Therapy (DHEA) Sales by Country (2020-2031)

3.7.3 Latin America Dehydroepiandrosterone Therapy (DHEA) Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Dehydroepiandrosterone Therapy (DHEA) Market Facts & Figures by Country

3.8.1 Middle East and Africa Dehydroepiandrosterone Therapy (DHEA) Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Dehydroepiandrosterone Therapy (DHEA) Sales by Country (2020-2031)

3.8.3 Middle East and Africa Dehydroepiandrosterone Therapy (DHEA) Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Dehydroepiandrosterone Therapy (DHEA) Sales by Type (2020-2031)

4.1.1 Global Dehydroepiandrosterone Therapy (DHEA) Sales by Type (2020-2025)

4.1.2 Global Dehydroepiandrosterone Therapy (DHEA) Sales by Type (2026-2031)

4.1.3 Global Dehydroepiandrosterone Therapy (DHEA) Sales Market Share by Type (2020-2031)

4.2 Global Dehydroepiandrosterone Therapy (DHEA) Revenue by Type (2020-2031)

4.2.1 Global Dehydroepiandrosterone Therapy (DHEA) Revenue by Type (2020-2025)

4.2.2 Global Dehydroepiandrosterone Therapy (DHEA) Revenue by Type (2026-2031)

4.2.3 Global Dehydroepiandrosterone Therapy (DHEA) Revenue Market Share by Type (2020-2031)

4.3 Global Dehydroepiandrosterone Therapy (DHEA) Price by Type (2020-2031)

5 Segment by Application

5.1 Global Dehydroepiandrosterone Therapy (DHEA) Sales by Application (2020-2031)

5.1.1 Global Dehydroepiandrosterone Therapy (DHEA) Sales by Application (2020-2025)

5.1.2 Global Dehydroepiandrosterone Therapy (DHEA) Sales by Application (2026-2031)

5.1.3 Global Dehydroepiandrosterone Therapy (DHEA) Sales Market Share by Application (2020-2031)

5.2 Global Dehydroepiandrosterone Therapy (DHEA) Revenue by Application (2020-2031)

5.2.1 Global Dehydroepiandrosterone Therapy (DHEA) Revenue by Application (2020-2025)

5.2.2 Global Dehydroepiandrosterone Therapy (DHEA) Revenue by Application (2026-2031)

5.2.3 Global Dehydroepiandrosterone Therapy (DHEA) Revenue Market Share by Application (2020-2031)

5.3 Global Dehydroepiandrosterone Therapy (DHEA) Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Jarrow Formulas

6.1.1 Jarrow Formulas Company Information

6.1.2 Jarrow Formulas Description and Business Overview

6.1.3 Jarrow Formulas Dehydroepiandrosterone Therapy (DHEA) Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Jarrow Formulas Dehydroepiandrosterone Therapy (DHEA) Product Portfolio

6.1.5 Jarrow Formulas Recent Developments/Updates

6.2 Acetar Bio-Tech

6.2.1 Acetar Bio-Tech Company Information

6.2.2 Acetar Bio-Tech Description and Business Overview

6.2.3 Acetar Bio-Tech Dehydroepiandrosterone Therapy (DHEA) Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Acetar Bio-Tech Dehydroepiandrosterone Therapy (DHEA) Product Portfolio

6.2.5 Acetar Bio-Tech Recent Developments/Updates

6.3 GNC

6.3.1 GNC Company Information

6.3.2 GNC Description and Business Overview

6.3.3 GNC Dehydroepiandrosterone Therapy (DHEA) Sales, Revenue and Gross Margin (2020-2025)

6.3.4 GNC Dehydroepiandrosterone Therapy (DHEA) Product Portfolio

6.3.5 GNC Recent Developments/Updates

6.4 Schiff Vitamins

6.4.1 Schiff Vitamins Company Information

6.4.2 Schiff Vitamins Description and Business Overview

6.4.3 Schiff Vitamins Dehydroepiandrosterone Therapy (DHEA) Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Schiff Vitamins Dehydroepiandrosterone Therapy (DHEA) Product Portfolio

6.4.5 Schiff Vitamins Recent Developments/Updates

6.5 Natrol

6.5.1 Natrol Company Information

6.5.2 Natrol Description and Business Overview

6.5.3 Natrol Dehydroepiandrosterone Therapy (DHEA) Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Natrol Dehydroepiandrosterone Therapy (DHEA) Product Portfolio

6.5.5 Natrol Recent Developments/Updates

6.6 Nature’s Bounty

6.6.1 Nature’s Bounty Company Information

6.6.2 Nature’s Bounty Description and Business Overview

6.6.3 Nature’s Bounty Dehydroepiandrosterone Therapy (DHEA) Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Nature’s Bounty Dehydroepiandrosterone Therapy (DHEA) Product Portfolio

6.6.5 Nature’s Bounty Recent Developments/Updates

6.7 Shanghai Jinli Biotech

6.7.1 Shanghai Jinli Biotech Company Information

6.7.2 Shanghai Jinli Biotech Description and Business Overview

6.7.3 Shanghai Jinli Biotech Dehydroepiandrosterone Therapy (DHEA) Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Shanghai Jinli Biotech Dehydroepiandrosterone Therapy (DHEA) Product Portfolio

6.7.5 Shanghai Jinli Biotech Recent Developments/Updates

6.8 Lisi (Xian) Bio-Tech

6.8.1 Lisi (Xian) Bio-Tech Company Information

6.8.2 Lisi (Xian) Bio-Tech Description and Business Overview

6.8.3 Lisi (Xian) Bio-Tech Dehydroepiandrosterone Therapy (DHEA) Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Lisi (Xian) Bio-Tech Dehydroepiandrosterone Therapy (DHEA) Product Portfolio

6.8.5 Lisi (Xian) Bio-Tech Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Dehydroepiandrosterone Therapy (DHEA) Industry Chain Analysis

7.2 Dehydroepiandrosterone Therapy (DHEA) Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Dehydroepiandrosterone Therapy (DHEA) Production Mode & Process Analysis

7.4 Dehydroepiandrosterone Therapy (DHEA) Sales and Marketing

7.4.1 Dehydroepiandrosterone Therapy (DHEA) Sales Channels

7.4.2 Dehydroepiandrosterone Therapy (DHEA) Distributors

7.5 Dehydroepiandrosterone Therapy (DHEA) Customer Analysis

8 Dehydroepiandrosterone Therapy (DHEA) Market Dynamics

8.1 Dehydroepiandrosterone Therapy (DHEA) Industry Trends

8.2 Dehydroepiandrosterone Therapy (DHEA) Market Drivers

8.3 Dehydroepiandrosterone Therapy (DHEA) Market Challenges

8.4 Dehydroepiandrosterone Therapy (DHEA) Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Shanghai Jinli Biotech

Lisi (Xian) Bio-Tech

List of Tables

Table 1. Global Dehydroepiandrosterone Therapy (DHEA) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Dehydroepiandrosterone Therapy (DHEA) Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Dehydroepiandrosterone Therapy (DHEA) Market Competitive Situation by Manufacturers in 2024

Table 4. Global Dehydroepiandrosterone Therapy (DHEA) Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Dehydroepiandrosterone Therapy (DHEA) Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Dehydroepiandrosterone Therapy (DHEA) Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Dehydroepiandrosterone Therapy (DHEA) Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Dehydroepiandrosterone Therapy (DHEA) Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Dehydroepiandrosterone Therapy (DHEA), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Dehydroepiandrosterone Therapy (DHEA), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Dehydroepiandrosterone Therapy (DHEA), Product Type & Application

Table 12. Global Key Manufacturers of Dehydroepiandrosterone Therapy (DHEA), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Dehydroepiandrosterone Therapy (DHEA) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dehydroepiandrosterone Therapy (DHEA) as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Dehydroepiandrosterone Therapy (DHEA) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Dehydroepiandrosterone Therapy (DHEA) Sales by Region (2020-2025) & (K Units)

Table 18. Global Dehydroepiandrosterone Therapy (DHEA) Sales Market Share by Region (2020-2025)

Table 19. Global Dehydroepiandrosterone Therapy (DHEA) Sales by Region (2026-2031) & (K Units)

Table 20. Global Dehydroepiandrosterone Therapy (DHEA) Sales Market Share by Region (2026-2031)

Table 21. Global Dehydroepiandrosterone Therapy (DHEA) Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Dehydroepiandrosterone Therapy (DHEA) Revenue Market Share by Region (2020-2025)

Table 23. Global Dehydroepiandrosterone Therapy (DHEA) Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Dehydroepiandrosterone Therapy (DHEA) Revenue Market Share by Region (2026-2031)

Table 25. North America Dehydroepiandrosterone Therapy (DHEA) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Dehydroepiandrosterone Therapy (DHEA) Sales by Country (2020-2025) & (K Units)

Table 27. North America Dehydroepiandrosterone Therapy (DHEA) Sales by Country (2026-2031) & (K Units)

Table 28. North America Dehydroepiandrosterone Therapy (DHEA) Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Dehydroepiandrosterone Therapy (DHEA) Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Dehydroepiandrosterone Therapy (DHEA) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Dehydroepiandrosterone Therapy (DHEA) Sales by Country (2020-2025) & (K Units)

Table 32. Europe Dehydroepiandrosterone Therapy (DHEA) Sales by Country (2026-2031) & (K Units)

Table 33. Europe Dehydroepiandrosterone Therapy (DHEA) Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Dehydroepiandrosterone Therapy (DHEA) Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Dehydroepiandrosterone Therapy (DHEA) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Dehydroepiandrosterone Therapy (DHEA) Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Dehydroepiandrosterone Therapy (DHEA) Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Dehydroepiandrosterone Therapy (DHEA) Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Dehydroepiandrosterone Therapy (DHEA) Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Dehydroepiandrosterone Therapy (DHEA) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Dehydroepiandrosterone Therapy (DHEA) Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Dehydroepiandrosterone Therapy (DHEA) Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Dehydroepiandrosterone Therapy (DHEA) Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Dehydroepiandrosterone Therapy (DHEA) Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Dehydroepiandrosterone Therapy (DHEA) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Dehydroepiandrosterone Therapy (DHEA) Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Dehydroepiandrosterone Therapy (DHEA) Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Dehydroepiandrosterone Therapy (DHEA) Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Dehydroepiandrosterone Therapy (DHEA) Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Dehydroepiandrosterone Therapy (DHEA) Sales (K Units) by Type (2020-2025)

Table 51. Global Dehydroepiandrosterone Therapy (DHEA) Sales (K Units) by Type (2026-2031)

Table 52. Global Dehydroepiandrosterone Therapy (DHEA) Sales Market Share by Type (2020-2025)

Table 53. Global Dehydroepiandrosterone Therapy (DHEA) Sales Market Share by Type (2026-2031)

Table 54. Global Dehydroepiandrosterone Therapy (DHEA) Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Dehydroepiandrosterone Therapy (DHEA) Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Dehydroepiandrosterone Therapy (DHEA) Revenue Market Share by Type (2020-2025)

Table 57. Global Dehydroepiandrosterone Therapy (DHEA) Revenue Market Share by Type (2026-2031)

Table 58. Global Dehydroepiandrosterone Therapy (DHEA) Price (US$/Unit) by Type (2020-2025)

Table 59. Global Dehydroepiandrosterone Therapy (DHEA) Price (US$/Unit) by Type (2026-2031)

Table 60. Global Dehydroepiandrosterone Therapy (DHEA) Sales (K Units) by Application (2020-2025)

Table 61. Global Dehydroepiandrosterone Therapy (DHEA) Sales (K Units) by Application (2026-2031)

Table 62. Global Dehydroepiandrosterone Therapy (DHEA) Sales Market Share by Application (2020-2025)

Table 63. Global Dehydroepiandrosterone Therapy (DHEA) Sales Market Share by Application (2026-2031)

Table 64. Global Dehydroepiandrosterone Therapy (DHEA) Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Dehydroepiandrosterone Therapy (DHEA) Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Dehydroepiandrosterone Therapy (DHEA) Revenue Market Share by Application (2020-2025)

Table 67. Global Dehydroepiandrosterone Therapy (DHEA) Revenue Market Share by Application (2026-2031)

Table 68. Global Dehydroepiandrosterone Therapy (DHEA) Price (US$/Unit) by Application (2020-2025)

Table 69. Global Dehydroepiandrosterone Therapy (DHEA) Price (US$/Unit) by Application (2026-2031)

Table 70. Jarrow Formulas Company Information

Table 71. Jarrow Formulas Description and Business Overview

Table 72. Jarrow Formulas Dehydroepiandrosterone Therapy (DHEA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Jarrow Formulas Dehydroepiandrosterone Therapy (DHEA) Product

Table 74. Jarrow Formulas Recent Developments/Updates

Table 75. Acetar Bio-Tech Company Information

Table 76. Acetar Bio-Tech Description and Business Overview

Table 77. Acetar Bio-Tech Dehydroepiandrosterone Therapy (DHEA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Acetar Bio-Tech Dehydroepiandrosterone Therapy (DHEA) Product

Table 79. Acetar Bio-Tech Recent Developments/Updates

Table 80. GNC Company Information

Table 81. GNC Description and Business Overview

Table 82. GNC Dehydroepiandrosterone Therapy (DHEA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. GNC Dehydroepiandrosterone Therapy (DHEA) Product

Table 84. GNC Recent Developments/Updates

Table 85. Schiff Vitamins Company Information

Table 86. Schiff Vitamins Description and Business Overview

Table 87. Schiff Vitamins Dehydroepiandrosterone Therapy (DHEA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Schiff Vitamins Dehydroepiandrosterone Therapy (DHEA) Product

Table 89. Schiff Vitamins Recent Developments/Updates

Table 90. Natrol Company Information

Table 91. Natrol Description and Business Overview

Table 92. Natrol Dehydroepiandrosterone Therapy (DHEA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Natrol Dehydroepiandrosterone Therapy (DHEA) Product

Table 94. Natrol Recent Developments/Updates

Table 95. Nature’s Bounty Company Information

Table 96. Nature’s Bounty Description and Business Overview

Table 97. Nature’s Bounty Dehydroepiandrosterone Therapy (DHEA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Nature’s Bounty Dehydroepiandrosterone Therapy (DHEA) Product

Table 99. Nature’s Bounty Recent Developments/Updates

Table 100. Shanghai Jinli Biotech Company Information

Table 101. Shanghai Jinli Biotech Description and Business Overview

Table 102. Shanghai Jinli Biotech Dehydroepiandrosterone Therapy (DHEA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Shanghai Jinli Biotech Dehydroepiandrosterone Therapy (DHEA) Product

Table 104. Shanghai Jinli Biotech Recent Developments/Updates

Table 105. Lisi (Xian) Bio-Tech Company Information

Table 106. Lisi (Xian) Bio-Tech Description and Business Overview

Table 107. Lisi (Xian) Bio-Tech Dehydroepiandrosterone Therapy (DHEA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Lisi (Xian) Bio-Tech Dehydroepiandrosterone Therapy (DHEA) Product

Table 109. Lisi (Xian) Bio-Tech Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Dehydroepiandrosterone Therapy (DHEA) Distributors List

Table 113. Dehydroepiandrosterone Therapy (DHEA) Customers List

Table 114. Dehydroepiandrosterone Therapy (DHEA) Market Trends

Table 115. Dehydroepiandrosterone Therapy (DHEA) Market Drivers

Table 116. Dehydroepiandrosterone Therapy (DHEA) Market Challenges

Table 117. Dehydroepiandrosterone Therapy (DHEA) Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Dehydroepiandrosterone Therapy (DHEA)

Figure 2. Global Dehydroepiandrosterone Therapy (DHEA) Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Dehydroepiandrosterone Therapy (DHEA) Market Share by Type: 2024 & 2031

Figure 4. Powder Product Picture

Figure 5. Tablet Product Picture

Figure 6. Other Product Picture

Figure 7. Global Dehydroepiandrosterone Therapy (DHEA) Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Dehydroepiandrosterone Therapy (DHEA) Market Share by Application: 2024 & 2031

Figure 9. Medicine

Figure 10. Laboratory

Figure 11. Global Dehydroepiandrosterone Therapy (DHEA) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Dehydroepiandrosterone Therapy (DHEA) Market Size (2020-2031) & (US$ Million)

Figure 13. Global Dehydroepiandrosterone Therapy (DHEA) Sales (2020-2031) & (K Units)

Figure 14. Global Dehydroepiandrosterone Therapy (DHEA) Average Price (US$/Unit) & (2020-2031)

Figure 15. Dehydroepiandrosterone Therapy (DHEA) Report Years Considered

Figure 16. Dehydroepiandrosterone Therapy (DHEA) Sales Share by Manufacturers in 2024

Figure 17. Global Dehydroepiandrosterone Therapy (DHEA) Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Dehydroepiandrosterone Therapy (DHEA) Players: Market Share by Revenue in Dehydroepiandrosterone Therapy (DHEA) in 2024

Figure 19. Dehydroepiandrosterone Therapy (DHEA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Dehydroepiandrosterone Therapy (DHEA) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Dehydroepiandrosterone Therapy (DHEA) Sales Market Share by Country (2020-2031)

Figure 22. North America Dehydroepiandrosterone Therapy (DHEA) Revenue Market Share by Country (2020-2031)

Figure 23. United States Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Dehydroepiandrosterone Therapy (DHEA) Sales Market Share by Country (2020-2031)

Figure 26. Europe Dehydroepiandrosterone Therapy (DHEA) Revenue Market Share by Country (2020-2031)

Figure 27. Germany Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Dehydroepiandrosterone Therapy (DHEA) Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Dehydroepiandrosterone Therapy (DHEA) Revenue Market Share by Region (2020-2031)

Figure 34. China Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Dehydroepiandrosterone Therapy (DHEA) Sales Market Share by Country (2020-2031)

Figure 42. Latin America Dehydroepiandrosterone Therapy (DHEA) Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Dehydroepiandrosterone Therapy (DHEA) Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Dehydroepiandrosterone Therapy (DHEA) Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Dehydroepiandrosterone Therapy (DHEA) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Dehydroepiandrosterone Therapy (DHEA) by Type (2020-2031)

Figure 53. Global Revenue Market Share of Dehydroepiandrosterone Therapy (DHEA) by Type (2020-2031)

Figure 54. Global Dehydroepiandrosterone Therapy (DHEA) Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Dehydroepiandrosterone Therapy (DHEA) by Application (2020-2031)

Figure 56. Global Revenue Market Share of Dehydroepiandrosterone Therapy (DHEA) by Application (2020-2031)

Figure 57. Global Dehydroepiandrosterone Therapy (DHEA) Price (US$/Unit) by Application (2020-2031)

Figure 58. Dehydroepiandrosterone Therapy (DHEA) Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions